♦♦ ♦♦ ♦ Objective: The effect of long-term use of high glucose dialysate on peritoneal structure and function, and its relation with accumulation of advanced glycosylation endproduct (AGE) in the peritoneum was investigated in this study. ♦♦ ♦♦ ♦ Methods: Dialysates with 4.25% glucose were injected into the peritoneal cavity of normal rats for 12 weeks without (PD, n = 7) and with (1 g/L, PD+AG, n = 7) aminoguanidine in their drinking water. Rats not having intraperitoneal (IP) injection served as control (n = 9). After 12 weeks of IP injection, a 2-hour peritoneal equilibration test (PET) was performed using 30 mL 4.25% glucose dialysate. Intraperitoneal volume (IPV), dialysate-to-plasma urea ratio at 2 hours (D 2 /P 2 ), the ratio of dialysate glucose at 2 hours to initial dialysate glucose (D 2 /D 0 ), and the peritoneal fluid absorption rate (Q a ) were evaluated. After the PET, samples of the parietal peritoneum were taken for hematoxylin and eosin (H&E) staining and immunohistochemical staining for AGE. ♦♦ ♦♦ ♦ Results: The IPV and D 2 /D 0 glucose were significantly lower and Q a and D 2 /P 2 urea significantly higher in the PD group than in the control group. Aminoguanidine reversed in part the changes in IPV and D 2 /P 2 urea in the PD group; it had no effect on Q a and D 2 /D 0 glucose. The H&E staining showed a linear mesothelial lining with negligible cells and capillaries in the narrow submesothelial space in the control group. Mesothelial denudation and submesothelial infiltration of monocytes and capillary formation were observed in the PD group. Mesothelial denudation was relatively intact in the PD+AG group compared with the PD group. Submesothelial monocyte infiltration and capillary formation in the PD+AG group were not as prominent as in the PD group. Positive AGE staining was found in the submesothelial space, vascular walls, and endomysium in the PD group, while it was markedly attenuated in PD+AG group and negligible in the control group. ♦♦ ♦♦ ♦ Conclusion: Long-term use of high glucose solutions induced peritoneal AGE accumulation and mesothelial denudation, and increased peritoneal permeability and peritoneal fluid absorption rate. Inhibition of peritoneal AGE accumulation prevented those functional and structural damages to the peritoneum.
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KEY WORDS: AGEs; peritoneal permeability; ultrafiltration; aminoguanidine. G lucose is the most commonly used osmotic agent in peritoneal dialysis (PD). Glucose is effective as an osmotic agent, inexpensive, readily available, and easily metabolized and may serve as a natural source of energy (1) . There are, however, some disadvantages related to using glucose as an osmotic agent. As glucose diffuses rapidly from the peritoneal cavity to the systemic blood, effective ultrafiltration time is short, only 2 -3 hours (2). Continuous glucose absorption from the peritoneal cavity induces or aggravates the glucose intolerance and hyperlipidemia observed in uremia (3) . Furthermore, high glucose concentration in dialysis solutions induces functional derangement of peripheral monocytes (4, 5) , peritoneal mesothelial cells (6) , and peritoneal monocytes (7) . High glucose induces transforming growth factor β (TGFβ) production in peritoneal mesothelial cells (8) (9) (10) . Increased TGFβ production in peritoneal mesothelial cells has been suggested to be an important mechanism of peritoneal fibrosis found in peritoneal dialysis (PD) patients after long-term use of high glucose dialysis solutions.
Histological examination of peritoneum from PD patients often reveals duplication of submesothelial basement membrane in both diabetic and nondiabetic patients, and acceleration of pre-existing duplication of capillary basement membrane in diabetic patients (11) (12) (13) (14) . These histological changes are similar to diabetic complications and are believed to be due to continuous exposure of the peritoneum to unphysiologically high ambient glucose.
Hyperglycemia is associated with the presence or progression of various complications in type I (15) and type II diabetes mellitus (16, 17) . One of the major consequences of prolonged hyperglycemia is accelerated formation of advanced glycosylation end-product (AGE) on long lived structural proteins (18) . AGE is excreted mainly by the kidneys, and therefore serum levels increase as renal function decreases (19) . Exogenous administration of AGE induced an increase in vascular permeability in normal animals (20) , and accumulation of AGE induced structural and functional alterations of tissue proteins (21) . The AGE peptide level in spent dialysate in PD patients is higher than plasma levels (22) . Peritoneal accumulation of AGE has been reported in PD patients (23) . The peritoneal accumulation of AGE and peritoneal permeability to small and large molecular solutes have been shown to increase with duration of continuous ambulatory peritoneal dialysis (CAPD) (23) ; however, the relation between peritoneal AGE accumulation and peritoneal permeability is yet to be elucidated.
Aminoguanidine inhibits AGE formation and protein cross-linking in vitro (24) . Administration of aminoguanidine to rats prevented diabetes-induced AGE formation and cross-linking of arterial wall connective tissue protein in vivo (24) , and also prevented increasing vascular permeability in aorta, skin, intestine, heart, vena cava, and brain tissue after exogenous injection of AGE in rats (20) .
The purpose of the study was to investigate the relation between peritoneal accumulation of AGE and peritoneal membrane function after long-term use of high glucose PD solutions. To elucidate the effect of peritoneal AGE accumulation on peritoneal permeability, we also investigated the effect of aminoguanidine on peritoneal AGE accumulation and peritoneal permeability.
METHODS

ANIMALS AND INTRAPERITONEAL (IP) INJECTION
Thirty normal male Sprague-Dawley rats (200 -250 g body weight) were used. Commercially available dialysis solution containing 4.25% glucose (Peritosol 425, Green Cross Ltd., Korea; Table 1 ) was injected (30 mL) into the peritoneal cavity of 20 rats, twice per day, for 12 weeks (PD group) after ether anesthesia. Aminoguanidine (1 g/L) was added to the drinking water of 10 (PD+AG group) of the 20 rats receiving IP injection from the beginning of the 12 weeks of IP injection. Another 10 rats served as control. Ether anesthesia was done in the control group in the same manner as in the PD and PD+AG groups. During the 12 weeks of IP injection, three rats each from PD and PD+AG groups and one rat from the control group died and were excluded from the study. The study was approved by the Clinical Research Council of Soon Chun Hyang University Hospital.
SURGICAL PROCEDURES
The rats were anesthetized with a single IP injection of pentothal sodium (100 mg/kg). After induction of anesthesia, rats were laid in supine position. The peritoneal cavity was opened through the linea alba and examined grossly. Inflammatory changes, loculated fluid collection, abscess formation, and color changes were not found. The peritoneal cavity was carefully tapped with clean gauzes to remove any remnant fluid in all groups, including the control group. A multiholed Silastic peritoneal catheter was inserted with the tip placed in the right lower quadrant of the peritoneal cavity. The abdominal wall was carefully sutured and the catheter was secured with a pursestring stitch below the xyphoid process. Femoral artery catheterization was performed to take blood samples.
PERITONEAL FUNCTION TEST
To initiate an experiment, 30 mL dialysis solution containing 4.25% glucose in a syringe prewarmed to 37°C was injected IP via a three-way valve over a period of 30 seconds and was allowed to remain in the peritoneal cavity for 2 hours. To calculate the peritoneal fluid absorption rate (Q a ), human serum albumin radiolabeled with 131 I (RISA, 18.5 kBq) was added to 30 mL dialysis solution immediately before the test. At the end of a 2-hour dialysis, peritoneal fluid was drained and the effluent volume was recorded. The abdominal cavity was then tapped with preweighed gauze. The peritoneal residual volume was calculated as the difference in gauze weights before and after tapping. The intraperitoneal volume (IPV) after a 2-hour dialysis was calculated by the sum of drained volume, residual volume, and sampling volume. The Q a was assumed equal to the RISA elimination rate. The RISA elimination rate was calculated as described in a previous report (25) . At the beginning of the peritoneal function study, 10 mL isotonic saline was subcutaneously injected to prevent dehydration during the study.
SAMPLING PROCEDURES
Blood samples (1 mL) were drawn at 0, 60, and 120 minutes through the indwelling femoral artery catheter. Dialysate samples (0.35 mL) were taken from fresh dialysis fluid during infusion (time 0), and at 3, 30, 45, 60, 75, 90, and 120 minutes after infusion to measure RISA activity on a gamma counter (Packard, Multipria 4, Meriden, CT, U.S.A.). Dialysate samples taken at 3 minutes and at 2 hours after the initiation of the peritoneal function test were used for measuring glucose and urea concentrations. Prior to each sampling, 1 mL of dialysate was flushed back and forth five times through the peritoneal catheter and three-way valve. The dialysate sample taken at 3 minutes after the dialysis solution infusion was defined as the baseline value.
ANALYTIC METHODS
Glucose concentrations in plasma and dialysate were measured by the glucose-6-phosphatase method (Youngdong Pharmaceutical Co., Seoul, Korea). Urea concentrations in plasma and dialysate were measured by the urease glutamate dehydrogenase method (Youngdong Pharmaceutical, Co.).
PATHOLOGY STUDIES
The parietal peritoneal samples were taken within 1 cm of the linea alba, between the xiphoid process and symphysis pubis, after the 2-hour peritoneal equilibration test (PET). The samples were fixed in 4% neutral paraformaldehyde solutions overnight and then blocked in paraffin. Hematoxylin and eosin (H&E) staining was performed. Microscopic findings were scored semiquantitatively as 1 for each finding of mesothelial denudation, monocyte infiltration in submesothelial space, and capillary formation, and 0 for each of intact mesothelial lining, no monocyte infiltration, and no capillary formation.
Immunohistochemistry of AGE was done using an AGE-specific polyclonal antibody provided by the Picower Institute, New York, NY, U.S.A. The tissue specimens were sliced into thin sections (4 µ thick) and then deparaffinized. The sections were washed with phosphate-buffered saline (PBS) for 20 minutes. Endogenous peroxidase activity was blocked by incubating the sections with 0.3% H 2 O 2 in methanol for 5 -30 minutes. The sections were washed with PBS and then incubated with 5% normal goat serum (Jackson Immunoresearch Laboratories, West Grove, PA, U.S.A.) in PBS at 37°C for 20 minutes. After removing the normal goat sera, the sections were incubated with anti-AGE antibody (1:5000) at 4°C overnight. The sections were washed with PBS and incubated with the second antibody, peroxidase-conjugated goat IgG fraction to rabbit IgG (Cappel Research Products, Costa Mesa, CA, U.S.A.), at room temperature for 2 hours. After washing three times with Tris buffer, the reaction was halted by the addition of diaminobenzidine (DAB)-H 2 O 2 solutions for 5 -30 minutes. After washing with Tris buffer, the slides were counterstained with hematoxylin. The staining intensity was graded semiquantitatively from 0 to 3, with 0 for negative, 1 for weak, 2 for moderate, and 3 for strong staining. Negative control staining was also performed using the antibody incubated with an excess of antigen (1.5 mg/mL as AGE bovine serum albumin), and no staining was confirmed in any preparation. Two of the authors and an anatomist from Catholic Medical School, Korea, blind to slide selection, examined the pathology slides.
STATISTICAL ANALYSIS
Statistical differences in IPV after 2-hour dialysis, dialysate-to-plasma urea ratio at 2 hours (D 2 /P 2 ), the ratio of dialysate glucose at 2 hours to initial dialysate glucose (D 2 /D 0 ), and the Q a among the three study groups were evaluated using analysis of variance (StatView II, Abacus Concepts, Cary, NC, U.S.A.). Numeric data of the microscopic findings of the parietal peritoneum and intensity of AGE staining were assessed using analysis of variance, with Bonferroni's correction for multiple comparisons (StatView II). A p value of less than 0.05 was considered to indicate statistical significance. Data are expressed as mean ± standard deviation (SD). Table 2 shows fluid transport characteristics during a 2-hour dialysis in the three groups. After the 2-hour dialysis, IPV was significantly lower in the PD group compared to the control group (p = 0.0001). The IPV in the PD+AG group was significantly higher than in the PD group (p = 0.004) and did not differ from that of the control group. The Q a was significantly higher in the PD group compared to the control group (p = 0.039), and was similar to the PD+AG group.
RESULTS
PERITONEAL TRANSPORT
Plasma concentration of urea increased during the 2-hour dialysis and attained an average 132% of the baseline value in all three groups. Dialysate concentration of urea gradually increased during the 2-hour dialysis: D 2 /P 2 urea was significantly higher in the PD group compared to the control (p = 0.03) and PD+AG groups (Table 3) .
Plasma glucose level increased and attained an average 250% of the initial value in all three groups at the end of a 2-hour dialysis. Dialysate concentration of glucose gradually decreased during the study: D 2 /D 0 glucose was significantly lower in the PD (p = 0.03) and PD+AG (p = 0.03) groups compared to the control group (Table 3) . PERITONEAL 
MORPHOLOGY
The peritoneal cavity after a 2-hour dialysis was grossly clean. Figure 1 shows the peritoneal morphology and the light microscopic findings of H&E staining and immunohistochemistry. The H&E staining revealed a thin linear mesothelial lining with narrow submesothelial space in the control group. Mesothelial cells were partially denuded and a marked monocyte infiltration and a few capillaries in the submesothelial space were noted in the PD group. Mesothelial lining was relatively intact in the PD+AG group. Infiltration of a few monocytes and capillary formation in the submesothelial space of the parietal peritoneum were also noted in the PD+AG group (Figure 1 ). Table 4 shows the results of the semiquantitative analysis of microscopic findings.
Immunohistochemical study of AGE showed a thin layer of positive staining at the mesothelial lining of the parietal peritoneum in the control group. In the PD group, strongly positive AGE staining was noted in the submesothelial space, capillary walls, and endomysium; these findings were not noted in the control group. AGE staining was most prominent in capillary walls. Aminoguanidine markedly attenuated the AGE staining. The intensity of AGE staining is shown in Table 5 .
DISCUSSION
In this study, long-term peritoneal use of high glucose dialysis solutions decreased ultrafiltration, increased peritoneal permeability to glucose and urea, and increased the Q a . Aminoguanidine reversed in part the decreased ultrafiltration and increased peritoneal permeability to urea, while it did not affect peritoneal permeability to glucose and the Q a . Although peritoneal membrane function is reported to remain stable after 3 years of CAPD in the majority of patients (26) (27) (28) , peritoneal permeability increases and ultrafiltration function decreases with time on CAPD (29-31). The present findings, such as increased peritoneal permeability to urea and glucose and decreased ultrafiltration volume, are in general agreement with previous reports (29) (30) (31) .
Peritoneal accumulation of AGE has been reported in nondiabetic patients on long-term PD (23, 32) and has been related to increased peritoneal permeability in long-term PD (23) . The present findings of increased peritoneal permeability to urea and glucose, together with strong positive staining for AGE in the peritoneal tissue, support the previous report (23) . The (23) . Cross-linking of AGE with the protein components of capillary basement membrane disturbs the integrity of the basement membrane and increases capillary permeability (33, 34) . Aminoguanidine inhibited AGE formation and cross-linking in vitro (24) . Aminoguanidine administration to rats inhibited diabetes-induced accumulation of AGE and abnormal cross-linking of connective tissue protein of the arterial wall (24) . In the present study, aminoguanidine attenuated AGE accumulation on capillaries and endomysium in the parietal peritoneum, and prevented decreased ultrafiltration and increased peritoneal permeability to urea after longterm peritoneal use of high glucose dialysis solutions. The effect of aminoguanidine on peritoneal AGE accumulation was more marked in capillary walls in the parietal peritoneum than in the submesothelial space. The present findings of prevention of decreased ultrafiltration and increased peritoneal permeability observed after long-term use of high glucose dialysis solutions by use of aminoguanidine suggest that AGE accumulation in the peritoneum altered the protein integrity of vascular walls and increased capillary permeability to small solutes. , and a few capillaries in the submesothelial space (CA) are noted in thePD group (B). In the PD+AG group, the mesothelial lining is relatively intact and infiltration of a few monocytes and capillary formation are also noted in submesothelial space of the parietal peritoneum (C), but remarkably less than in the PD group. Immunohistochemical staining for advanced glycosylation endproduct (AGE) shows a strong positive reaction (arrow heads) in the submesothelial space (E), capillary walls and endomysium in PD group (H), while these findings are not noted in the control group (D,G). Aminoguanidine attenuated AGE staining in the submesothelial space, capillary walls, and endomysium (F,I) (magnification ×150).
Control
PD group PD+AG group It has to be noted that the increased glucose absorption observed after long-term use of high glucose dialysis solutions was not affected by the use of aminoguanidine in the present study, although increased peritoneal permeability to urea was reversed by using aminoguanidine. Peritoneal urea transport is mainly by simple passive diffusion, and the urea transport rate is dependent on peritoneal surface area and permeability (25) . However, peritoneal glucose transport is not as simple and/or passive as peritoneal urea transport, and is affected by glucose and/or insulin concentrations (35) . Glucose is taken up by cells and used as an energy source. Intracellular glucose uptake is mediated by glucose transporters that facilitate glucose transport into the cells (36) . Peritoneal permeability to glucose decreased with the inhibition of glucose transporters (37, 38) . The use of a glucose transporter inhibitor reversed the increased peritoneal glucose absorption that is observed after long-term use of glucose-containing dialysis solutions (38) . It can be assumed that increased peritoneal permeability to glucose after long-term use of high glucose dialysis solutions is not due only to the increased peritoneal permeability directly related with peritoneal AGE accumulation, but is also due to altered other transport mechanisms, such as intracellular glucose uptake through a glucose transporter.
In the present study, the Q a was higher in the PD and PD+AG groups. Aminoguanidine did not affect the Q a . An increased Q a is one of the possible mechanisms for decreased peritoneal ultrafiltration func- (39) . The Q a is known to be higher in PD patients and liver cirrhosis patients with ascites. Peritoneal hydrostatic pressure in rat was increased after IP infusion of dialysis solution (25) . Although peritoneal hydrostatic pressure was not measured in the present study, it can be assumed that continuous IP use of dialysis solutions increased the IP hydrostatic pressure in the PD and PD+AG groups, and this increased peritoneal hydrostatic pressure could be the major reason for the increased Q a in the PD and PD+AG groups in this study. Intraperitoneal injection of high glucose dialysis solutions induced denudation of mesothelial cells and monocyte infiltration. Although mesothelial denudation is usually observed during peritonitis (40) , typical signs of peritonitis, such as a fibrin deposit covering the mesothelial layer, or polymorphonuclear leukocyte infiltration (41), were not observed in the present study. High glucose per se is toxic to mesothelial cells (4) (5) (6) . Denudation of mesothelial cells has been observed in patients on CAPD without acute peritonitis episodes (42) . Ultrastructure and characteristics of mesothelial cells were not different between humans and rodents (43) . It can be assumed that the mesothelial damage observed in the present study was due mainly to IP use of high glucose solutions.
Exogenous administration of AGE in nondiabetic rats increased the AGE content of aortic tissue and was associated with increased vascular permeability (20) . The considerable submesothelial monocyte infiltration after the use of high glucose dialysis solutions in the present study is comparable with the previously reported finding of mononuclear cell migration in the subendothelial and periarteriolar spaces after exogenous administration of AGE (20) . AGE induced monocyte migration across an intact endothelial cell monolayer and expression of platelet-derived growth factor (44) . Accumulation of AGE in the peritoneum, structural protein alterations of the peritoneal capillaries, inflammatory cell infiltration, and cytokine release as a consequence of AGEinduced cell activation may have resulted in increased peritoneal permeability and decreased ultrafiltration function after long-term use of high glucose dialysis solutions.
The present results showing protective effects of aminoguanidine on peritoneal AGE accumulation, mesothelial denudation, submesothelial monocyte infiltration, increased peritoneal permeability, and decreased ultrafiltration indicate that peritoneal AGE accumulation is directly related with structural and functional alterations of the peritoneum after longterm use of high glucose solutions.
It has to be noted that mesothelial cells are very easy to remove from biopsy specimens (41) , and our method of tapping the peritoneal cavity with gauze may have damaged the mesothelial cells. Tapping the peritoneal cavity was done in all three groups, including the control group, before and after a 2-hour PD. Denudation of mesothelial cells was noted mainly in the PD group, while they were intact in the control group. Therefore, it is not likely that tapping of the peritoneal cavity was a considerable cause of the denudation of mesothelial cells in the PD group.
In conclusion, increased peritoneal permeability to urea, decreased ultrafiltration, and mesothelial cell damage observed after long-term use of high glucose solution are related to peritoneal AGE accumulation. However, increased peritoneal permeability to glucose and peritoneal fluid absorption rate after long-term use of high glucose dialysis solutions were not affected by use of aminoguanidine. Therefore, it can be assumed that peritoneal glucose transport and peritoneal fluid absorption rate are not directly related to AGE-related peritoneal damage.
